The Prescription: 1st March 2018 Issue
Editor’s EmulsionPSM INDIA Capsules Drug Laws & Policy Injections Pharma Injections DRUG DOPES National Injections Global Injections PSM Pill DOSE OF THE DAY FAQ Subscriber's Symptom UpComing Events Laughter Dose Blog Addict Contact Us
News Archive

Pooja Khaitan

Wishing all our readers a very Happy Holi. May the spirit of this festival leave you drenched with joy and may your life be coloured with hues of happiness!

Heartiest Congratulations to India’s new Drug Controller General, Dr. S Eswara Reddy and sincere thanks to our outgoing DCGI, Dr. G.N Singh for an effective and applaudable innings when in office. PSM India wishes Dr.Reddy all the best in his tenure and extends support at all times.

I take this opportunity in inviting all our readers to our 15th March event on World Consumer Rights Day. Every patient is a consumer and every consumer has been a patient some point of time in life. Let’s come together to stand strong as aware patients and consumers and help create a nation where every consumer is respected, irrespective of religion or financial status; where affordable healthcare becomes the right of every citizen; where there is access to safe and quality medicines always and where patients strongly voice themselves on issues such as private hospitals making profits of up to 1,737% on drugs, consumables and diagnostics, accounting for about 46% of a patient’s bill. Read details on this in our PSM India Capsules.


Do not hesitate to mail your comments on this edition to help us further improve. We appreciate your support and trust in us and are happy to have you as our loyal reader.
Feedback is what keeps us going. Should you have any query or question, please feel free to get in touch with us. Write to me on

The request we made in our 1st January issue of The Prescription of each one touching 5 lives this year, including yourself, with your positive actions remains to be seen. Post your pics on our facebook wall or chirp it on our twitter handle. Go ahead and reach out.

Stay Healthy. Stay Protected.

Pooja Khaitan

The Prescription


“Our mission is to enhance public health by assuring the safety, efficacy and quality of drugs, cosmetics and medical devices. Our vision is to protect and promote healthcare in India.”

Dr. S Eswara Reddy,
Drugs Controller General of India (DCGI)

PSM India Capsules

Join Us On 15th March, 2018, World Consumer Rights Day

Private Hospitals Make 1700% Profit On Consumables

An analysis of bills from four reputed private hospitals in Delhi and NCR by the National Pharmaceutical Pricing Authority (NPPA) has revealed that they are making profits of up to 1,737% on drugs, consumables and diagnostics and that these three account for about 46% of a patient’s bill. The analysis, released on Tuesday, noted that “the major beneficiaries of profits in all these cases because of inflated MRPs have been hospitals rather than drugs and devices’ manufacturers.

Read More
Study: Most ICU Patients Infected Via Ventilators

Ventilators may be intended to offer life support for critically-ill patients but they can also increase the risk of mortality by being carriers of multi-drug resistant bacteria, shows a study in seven leading tertiary care hospitals spread across the country.

Read More
Drug Laws & Policy Injections
Government To Create A Separate Ministry For Medical Devices: Ananth KumarBengaluru, 19 Feb 2018: The Indian Medical Device Industry is enthused to learn of huge opportunities coming up through the Government’s envisaged program Modicare aimed at providing Universal Healthcare Coverage to 500 million people. Inaugurating the 3rd Global Conference on Pharma Industry and Medical Devices today at Bengaluru, Union Minister for chemicals & Fertilizers. Ananth Kumar reiterated that the government’s flagship program, Modicare will unleash huge growth opportunities and challenges for the Indian pharma sector through explosive demand.Read More
NPPA's Directive To Hospitals To Mention Cost Of Consumables To Help Check Prices Of Consumables Used In Angioplasty New Delhi, 14 Feb 2018: The National Pharmaceutical Pricing Authority’s (NPPA) decision to direct healthcare institutions to mention the cost of main consumables during angioplasty procedure will help increase transparency in hospital billing and reduce treatment cost for patients, say healthcare activists and advocacy groups.Read More
Delhi Medical Council To Conduct Survey In Delhi To Estimate The Number Of QuacksNew Delhi, 19 Feb 2018: The Delhi Medical Council (DMC), as statutory body that governs the practice of modern medicine in the state, will undertake survey to estimate the number of quacks in the city. Till now, the council has been going with a rough figure of 50,000, although officials remain unaware of how the figure was arrived at. Read More
PIL In HC For Modern Blood Testing SystemCuttack, 12 Feb 2018: A public interest litigation has sought Orissa High Court's intervention to introduce Nucleic Acid Testing-Polymerase Chain Reaction (NAT-PCR) blood testing facility at all blood banks in the state. Read More
NPPA Revises Ceiling Prices Of Nine FormulationsNEW DELHI, 13 FEB 2018: The National Pharmaceutical Pricing Authority has revised upwards the ceiling prices of nine scheduled formulations used to treat a range of ailments from infertility in women and arthritis to seizures. The price of Clomiphene tablet 50mg (1 tablet) has been raised to ₹7.56 from ₹6.76, while a 100-mg tablet is now priced at ₹11.08 up from ₹10.62. Read More
CDRI To Unveil Osteoporosis MedicineLUCKNOW, 17 FEB 2018: At its 67th Annual Day on Saturday, Central Drugs Research Institute (CDRI) will launch its anti-osteoporosis agent. This medical formulation developed by CDRI's bone biology department will help prevent glucocorticoid-induced osteoporosis - a type of osteoporosis caused by medication. Glucocorticoid is a class of steroid hormones present in some medicines which leads to this type of osteoporosis. Read More
Pharma Injections
Online Pharmacy Medlife Launches Private Label Generic DrugsBengaluru, 12 Feb 2018: Online pharmacy Medlife is launching its private label generic drugs 'Pure Generics'. The company is looking to launch about 30 generic drugs and 40 Over-The-Counter (OTC) products by the next financial year.Read More
Big Data To Help Online Pharmacies Stay In Shape BENGALURU, 16 FEB 2018: Epharmacy 1mg Technologies’ chief executive Prashant Tandon has set up a small team of data scientists whose only job is to tinker around with available data and come up with interesting models with a potential to be turned into products in the near future.Read More
US FDA Lifts Warning Letter Issued To USV’s Daman Facility Mumbai, Feb 20, 2018: The drug firm, USV Private Ltd. said today that the US Food and Drug Administration (USFDA) lifted its warning letter issued in March 2017 to the Daman facility, following corrective actions taken by the company. USV Daman manufactures aseptic and oral solid dosage products for the US market. Read More
Pharma Units To Face Action For Failed Samples SHIMLA, 15 FEB 2018: Himachal Pradesh health minister Vipin Parmar said the state government would take stern action against drug manufacturers whose samples had failed the quality test recently. Read More
MTP Kits Being Sold Illegally In Raigad District Navi Mumbai, 15 Feb 2018: The Raigad Pharmacist Forum has alleged that kits for medical termination of pregnancy (MTP) are being sold illegally across the district. A group of operators from Mumbai allegedly bring kits from outside the state and sell it to doctors in rural areas. Read More
61% Stents Used Last Year Were Made In India New Delhi, 14 Feb 2018: If National Pharmaceuticals Pricing Authority (NPPA) chairman Bhupendra Singh’s tweet on Tuesday afternoon is any indication, the ‘Make in India’ slogan has truly worked for stents. A day after he announced a further cut in stent prices, Singh said 61% of the stents distributed in the country in 2017 were manufactured by Indian companies. Read More
Drug Dopes
Updated LIST OF NEW DRUGS APPROVED FROM 01-01-2018 TILL DATE BY NEW DRUGS DIVISION, CDSCO, FDA Bhawan, New Delhi List of New Drug Approved by FDA Read More
10-Year Jail, 3 Lakh Fine On Firm OwnerFaridkot, 12 Feb 2018: For selling spurious and substandard drugs, the court of Additional District and Sessions Judge today awarded 10-year rigorous imprisonment and imposed ₹ 3 lakh fine on the owner-cum-director of a Nalagarh-based pharmaceutical company. Read More
Pentazocine Vials Used For Drug Peddling, Seized In HyderabadHYDERABAD, 13 FEB 2018: Pentazocine vials, one of the powerful pain killers and sedatives, procured to reportedly sell to drug addicts in the city, were seized by Telangana Prohibition and Excise department officials on Monday. While MRP of the highly regulated vial is ₹ 6, it was being sold by the accused Y Sunil Dev at ₹ 1,500 to ₹ 2,000. Senior anesthetists said medically, it is used during and after surgery to relieve patients from pain and to put them to sleep. However, regular usage leads to addiction. Read More
Maha FDA Prosecutes Mumbai-Based Stockist For Illegal Sale Of Orthopaedic Implants To 22 Stockists In The State Mumbai, 13 Feb 2018: The Maharashtra Food and Drug Administration (FDA) has filed a case in the civil court against a Mumbai-based wholesaler for illegal sale of orthopaedic implants to 22 stockists in the state without a valid license. The state regulator suspects this as part of a larger cartel working in the state. Read More
Medicine Shock Reveals Racket Patna, 12 Feb 2018: The drug control administration's recent raids on medicine shops on Govind Mitra Road has unearthed a racket of making fake medicines with the label of an American pharmaceutical company. Read More
Import Of Growth Drug Oxytocin May Be Banned To Curb Misuse New Delhi, 19 Feb 2018: The Indian government is likely to ban the import of controversial growth drug Oxytocin in a bid to curb its misuse by dairy owners and farmers who use it to boost milk production and increase size of vegetables. Read More
Did ‘Wrong Injection’ Cause Kidney Failure? GHAZIABAD, 17 FEB 2018: An FIR has been registered against two doctors and a compounder of a private hospital here for allegedly injecting a wrong medicine to a woman, causing failure of both her kidneys. Read More
National Injections
Dr S Eswara Reddy Appointed As New DCGI New Delhi, 21 Feb 2018: Joint Drugs Controller Dr S Eswara Reddy has been appointed as the new Drugs Controller General of India (DCGI) for the next three months till regularly appointed person takes charge. According to a circular issued by the Ministry of Health and Family Welfare, Dr GN Singh has been relieved from the post with immediate effect. Read More
As Demand For Quality Drugs Increase, Lack Of Funds Hampers Safety RevampNew Delhi, 13 Feb 2018: As the need for good quality drugs is growing in India, states are grappling with the lack of adequate manpower and other facilities that can make inspections easier. Until recently, the Andhra Pradesh drug controller did not even have an office to operate from, according to a submission of the director-general of the Drug Controller Administration of Andhra PradeshRead More
Antibiotics Use In India Up By 66% In 10 Years Lucknow, 16 Feb 2018: The arithmetic is disturbing. In India, 1,300 crore antibiotic pills are swallowed by patients annually compared to 1,000 crore pills used in China and 700 crore pills in the USA, according to Public Health Research Organization Centre for Disease Dynamics, Economics and Policies Report on Antibiotics 2015. Read More
IIT-M In Process Of Creating India-Specific Cancer Genome Database Chennai, 18 Feb 2018: IIT-Madras is in the process of creating an India-specific cancer genome database aimed at early detection and development of better treatment strategy for the disease. Read More
Blood Donors Dissatisfied Over Working Of Blood Banks Udaipur, 16 Feb 2018: Regular blood donors of Udaipur city have expressed dissatisfaction over the working of blood banks. They served a notice to blood bank in this matter. Read More
Complaints Over Medical Bills: Centre Seeks States' Response New Delhi, 22 Feb 2018: With complaints mounting against private hospitals over inflated medical bills, the ministry of health and family welfare has sought a response from all states on implementation of the Clinical Establishments (Registration and Regulation) Act, 2010 that aims to monitor, assess and regulate laboratories, hospitals and health centres. Read More
Global Injections
Counterfeit Drugs Are A Problem Around The World February 20, 2018: A report published by the World Health Organization released in November 2017 estimated that 10% of medicines in developing countries are false or substandard, but that does not mean that counterfeit medicines do not also happen in developed countries. Here is a quick update on several international incidents that we want to make sure you know about: Read More
US FDA Floats New Rules For Testing Alzheimer's Drugs Maryland, 16 Feb 2018: For years now the gold standard for R&D in Alzheimer’s disease has focused on generating convincing evidence that any new therapy being studied could slow the cognitive decline of patients and help preserve their ability to perform the kind of daily functions that can keep a patient independent for a longer period of time. Read More

Tests For Women Using “Miracle” Fibroids Drug Amid Link To Serious Liver Damage Aberdeen, UK, 21 Feb 2018: Doctors have been ordered to stop prescribing Esmya (Ulipristal Acetate) to women with uterine fibroids while the European Medicines Agency (EMA) carries out a review of its side effects.Read More

US FDA Expands Treatment Window For Use Of Clot Retrieval Devices In Certain Stroke Patients Maryland, 15 Feb 2018: The U.S. Food and Drug Administration today cleared the use of the Trevo clot retrieval device to treat certain stroke patients up to 24 hours after symptom onset, expanding the device’s indication to a broader group of patients. This device is cleared for use as an initial therapy for strokes due to blood clots (also known as an acute ischemic stroke) to reduce paralysis, speech difficulties and other stroke disabilities and only as an addition to treatment with a medication that dissolves blood blots called tissue plasminogen activator (t-PA).Read More

DEA Creates New Resource To Help Distributors Avoid Oversupplying Opioids WASHINGTON, 14 FEB 2018: The U.S. Drug Enforcement Administration has launched a new tool to assist drug manufacturers and distributors with their regulatory obligations under the Controlled Substances Act. This new resource is an example of the many ways DEA is working collaboratively with its 1.73 million registrants to combat the ongoing opioid epidemic in the United States.Read More

US FDA: MRI Isotope Can Now Be Produced In The United States Maryland, 8 Feb 2018: FDA has played a major role in the groundbreaking effort to develop a new imaging technology – the RadioGenix System. This new technology was the result of a broad collaboration across the federal government and industry, and has the potential to benefit many patients as well as restore the U.S. ability to domestically supply a critical medical diagnostic tool for the first time in 30 years.Read More


Canadian Pharmacy Sells Counterfeit Cancer Drugs To Americans, Continues Business Despite U.S. Prosecution

February 21, 2018: In December 2017, the Wall Street Journal reported that plea agreements were outstanding in cases against, two subsidiaries, and CEO Kris Thorkelson. The original indictments alleged “CanadaDrugs’ business focused on the illegal importation and sale of prescription drugs that had not been approved by the FDA for use in the United States…”. This included counterfeit Avastin and other non-FDA approved medications discovered in 2012 by the FDA.

Read More

30 Pounds Of Fentanyl Discovered By Massachusetts Law Enforcement

February 13, 2018: According to the Boston Globe, a long-term investigation involving the efforts of multiple law enforcement agencies led to 33 arrests, the breaking up of a drug ring with direct ties to the Sinaloa Cartel, and the seizure of 30 pounds of fentanyl. That amount of fentanyl could cause over 4.5 million fatal overdoses, enough to kill over 65% of the state’s population. U.S. Drug Enforcement Administration, Massachusetts State Police, and the Boston, Braintree, and Randolph, MA police departments all participated in the case.

Read More

Frequently Asked Questions All you wanted to know on Universal Health Coverage
Q1: What does Universal Health Coverage entail for India?
Ans: "Universal coverage" refers to a scenario where everyone is covered for basic healthcare services. This is a scheme, under which all Indian citizens, regardless of their economic, social or cultural backgrounds will have the right to affordable, accountable and appropriate health services of assured quality defined in a published package of services and benefits. It is also a supplemental system of financing to protect people from increasing medical expenses.
Q2: Why is UHC being offered now?
Ans: It is important for all Indians to have access to quality health care regardless of your financial status such as where you live or how much income that you earn. It is also necessary for us to improve the quality of health care at our hospitals and other health care institutions.Read More>>>


How Scientific Is Western Medicine?

Article contributed by our subscriber, Ms.Sujata Sachdev, Chandigarh. If you wish to share articles on healthcare, and see them published here, please mail them to our Editor-in-Chief,

Clinical trials are research studies that aim to establish whether a medical strategy, treatment or device is safe for use or consumption by humans. These studies may also suggest which medical approaches prove most effective for specific conditions or groups of people. They advance medical knowledge. Clinical trials are the cornerstone of Western medicine. They provide the most reliable data to assist in healthcare decision-making. Read More

Upcoming Events
UpComing Events
Click Here For More Events
Laughter Dose
Blog Addicts
Mrs. Ronita Jain, Public Health Executive Loads of wishes for your good work PSM India. You have become a consistently growing public forum in our Country!
Ms. Nikita Dhami , Pharma academic ProfessionalDear PSM India, your aim towards tackling counterfeiting and improving patient safety is motivating and inspiring us
Dr. Rahul Raina , MD Medicine Thanks a lot for the great work done during the past so many years. Wishing you all the very best.
This Newsletter is brought to you by
© 2011 Partnership for Safe Medicines India
F-9, 2nd floor, Kailash Colony, New Delhi -110048;;
Disclaimer : Our newsletter endeavors to compile patient safety information from various sources . PSM India may not be held responsible for any article published in The Prescription.